Market leadership Position MR Solutions as a world leader in MRI technology with a track record of dry, cryogen-free preclinical systems and spectrometers, highlighting opportunities to upsell upgrades, maintenance contracts, and expansion into academic and industry labs investing in high-resolution imaging.

Expansion potential Leverage extensive installation footprint (over 2,000 installations) and international awards to pursue new contracts with biomedical research facilities, universities, and pharma, offering turnkey preclinical imaging solutions and multimodal imaging capabilities.

Upgrades and integration Market EVO Spectrometers and dry magnet technology as upgrade paths for existing MRI units and as core components for new systems, emphasizing compatible software control, modular upgrades, and improved image quality to hospital and research imaging centers.

Awards as proof Highlight Queen’s Awards for Enterprise and other recognitions to build credibility with procurement teams, supporting proposals for research grants, international collaborations, and long-term R&D partnerships.

Cost and efficiency focus Emphasize helium-free, cryogen-free operation and compact benchtop designs as compelling total-cost-of-ownership advantages for mid-size labs and startups seeking scalable, lower-maintenance MRI solutions and faster deployment timelines.